Farmakologisk långtidsbehandling vid ADHD : Hur skiljer sig substanserna metylfenidat, lisdexamfetamin och atomoxetin?
Attention Deficit Hyperactivity Disorder (ADHD) is a neuropsychiatric disability characterised by difficulties in paying attention, excessive activity and actions without thinking about the consequenses. Symptoms vary among different individuals in how the disability expresses. Symptoms also vary a...
| Main Author: | |
|---|---|
| Format: | Others |
| Language: | Swedish |
| Published: |
Linnéuniversitetet, Institutionen för kemi och biomedicin (KOB)
2019
|
| Subjects: | |
| Online Access: | http://urn.kb.se/resolve?urn=urn:nbn:se:lnu:diva-84877 |